Observations during the treatment with antithrombin-III concentrate of a case of a tampon-related toxic shock syndrome and disseminated intravascular coagulation. Discrepancies between functional and immunologic determinations of antithrombin.
作者信息
Jespersen J, Rasmussen N R, Toftgaard C
出版信息
Thromb Res. 1982 Jun 15;26(6):457-62. doi: 10.1016/0049-3848(82)90317-6.
PMID:7112521
Abstract
摘要
相似文献
1
Observations during the treatment with antithrombin-III concentrate of a case of a tampon-related toxic shock syndrome and disseminated intravascular coagulation. Discrepancies between functional and immunologic determinations of antithrombin.
Thromb Res. 1982 Jun 15;26(6):457-62. doi: 10.1016/0049-3848(82)90317-6.
2
3
Toxic shock syndrome.
Am J Nurs. 1981 Jan;81(1):82-5.
4
[Disordered hemostasis related to sepsis and SIRS].
Internist (Berl). 1998 May;39(5):479-84. doi: 10.1007/s001080050199.
5
[Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
Klin Padiatr. 1992 May-Jun;204(3):134-40. doi: 10.1055/s-2007-1025338.
6
[Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
Anesteziol Reanimatol. 2007 Mar-Apr(2):42-4.
7
[Therapy with antithrombin III in burned children--pilot study].
Haematologica. 1990 Mar-Apr;75 Suppl 2:33-40.
8
Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
Chest. 1993 Sep;104(3):882-8. doi: 10.1378/chest.104.3.882.
9
The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
Intensive Care Med. 1998 Dec;24(12):1344. doi: 10.1007/pl00022666.
10
Therapeutic use of antithrombin concentrate in sepsis.
Semin Thromb Hemost. 1998;24(2):183-94. doi: 10.1055/s-2007-995839.
引用本文的文献
1
Platelet factor 4 (PF4) in septicaemia.
Infection. 1988 Sep-Oct;16(5):273-6. doi: 10.1007/BF01645070.
Zotero 插件